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Abstract
Background: In Australia, chlamydia is the most commonly notifiable infection and over the past ten years
chlamydia and gonorrhoea notification rates have increased. Aboriginal compared with non-Aboriginal Australians
have the highest notifications rates of chlamydia and gonorrhoea. Regular testing of young people for chlamydia and
gonorrhoea is a key prevention strategy to identify asymptomatic infections early, provide treatment and safe sex
education. This study evaluated if a sexual health quality improvement program (QIP) known as SHIMMER could
increase chlamydia and gonorrhoea testing among young people attending four Aboriginal primary health care
services in regional areas of New South Wales, Australia.
Methods: We calculated the proportion of 15–29 year olds tested and tested positivity for chlamydia and gonorrhoea
in a 12-month before period (March 2010-February 2011) compared with a 12-month QIP period (March 2012-February
2013). Logistic regression was used to assess the difference in the proportion tested for chlamydia and gonorrhoea
between study periods by gender, age group, Aboriginal status and Aboriginal primary health service. Odds ratios (OR)
and their 95 % confidence intervals (CIs) were calculated with significance at p < 0.05.
Results: In the before period, 9 % of the 1881 individuals were tested for chlamydia, compared to 22 % of the 2259
individuals in the QIP period (OR): 1.43, 95 % CI: 1.22-1.67). From the before period to the QIP period, increases were
observed in females (13 % to 25 %, OR: 1.32, 95 % CI: 1.10-1.59) and males (3 % to 17 %, OR: 1.85, 95 % CI: 1.36-2.52). The
highest testing rate in the QIP period was in 15–19 year old females (16 % to 29 %, OR: 1.02, 95 % CI: 0.75-1.37), yet the
greatest increase was in 20–24 year olds males (3 % to 19 %, OR: 1.65, 95 % CI: 1.01-2.69). Similar increases were seen in
gonorrhoea testing. Overall, there were 70 (11 %) chlamydia diagnoses, increasing from 24 in the before to 46 in the QIP
period. Overall, 4 (0.7 %) gonorrhoea tests were positive.
Conclusions: The QIP used in SHIMMER almost tripled chlamydia and gonorrhoea testing in young people and found
more than twice as many chlamydia infections. The QIP could be used by other primary health care centres to increase
testing among young people.
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Background
Chlamydia is the most commonly notified infectious dis-
ease in Australia, the United States of America (US) and
the most commonly reported sexually transmissible infec-
tion (STI) among 16–24 year olds in the United Kingdom
(UK) [1–3]. In Australia, the highest chlamydia notifica-
tion rates are in females, 15–29 year olds and young
Aboriginal and Torres Strait Islander (hereafter referred
to as ‘Aboriginal’) people living in non-urban areas [1, 4].
In 2013, notification rates among Aboriginal compared
with non-Aboriginal people in Australia were three
times greater for chlamydia and 14 times greater for
gonorrhoea [1].
In 2011, the Australian Bureau of Statistics (ABS) esti-
mated that there were 669881 Aboriginal people, which
accounts for approximately 3 % of the Australian popula-
tion [5]. The number of Aboriginal people varied across the
Australian jurisdictions with the largest residing in New
South Wales (208476) followed by Queensland (188954)
[5]. The median age of Aboriginal people was 21 years
compared with 37 years in non-Aboriginal people [6], with
a higher proportion of Aboriginal compared with non-
Aboriginal people living in remote areas [7]. Aboriginal
compared with non-Aboriginal people have higher rates of
chronic and communicable diseases and unemployment;
and lower levels of home ownership, school completion
and life expectancy [7]. As a result, the Australian govern-
ment has released a number of national strategies to reduce
the disparity between Aboriginal and non-Aboriginal
people, including the Fourth National Aboriginal and
Torres Strait Islander Blood Borne Viruses and Sexually
Transmissible Infection Strategy, 2014–2017 [8].
Chlamydia is predominantly asymptomatic [9], and gon-
orrhoea is mostly asymptomatic in females and in about
half of males [9]. This highlights that testing is an important
prevention strategy to identify infections early, provide
treatment, prevent poor reproductive health outcomes
from developing and prevent transmitting the infections to
others. If left untreated, chlamydia and gonorrhoea infec-
tion can lead to pelvic inflammatory disease (PID) [10],
ectopic pregnancy [11] and infertility [12].
STI guidelines in the US and UK recommend annual
chlamydia testing in 16–24 year old females [2, 3], and
Australian STI guidelines recommend annual chlamydia
testing among sexually active 15–29 year old females
and males [13]. Australian STI guidelines for Aboriginal
people recommend gonorrhoea testing in 15–39 year
olds where the prevalence is high [14], for example in
remote areas of Australia [1]. Also improvements in
laboratory testing has influenced gonorrhoea testing in
Australia with a recent study finding that between 2007
to 2012 there has been a 32 % increase in laboratories
using duplex nucleic acid amplification (NAAT) to test
for chlamydia and gonorrhoea [15]. NAAT can test urine
or swab specimens for chlamydia and gonorrhoea at the
same time, even if a test for only one organism was
requested.
In Australia, it is estimated that 85 % of females and 64 %
of males aged 16–29 years attend a primary health care
service annually for their health care needs [16]. Aboriginal
Community Controlled Health Services (ACCHS) are
primary health care centres which provide culturally
appropriate medical, allied health and health educa-
tion to Aboriginal people [17]. There are an estimated
142 ACCHS in Australia and 42 in New South Wales
(NSW) [17].
Over the past decade, a number of interventions have
been trialed in primary health care centres that have
aimed to increase STI testing, including quality improve-
ment programs (QIP) [18, 19]. QIP involves collecting
data, visiting the health centre regularly, presenting the re-
sults to clinic staff and facilitating a discussion with staff
to develop strategies which could improve clinical man-
agement of an infection and monitor the clinics perform-
ance over time. A study conducted in paediatric clinics in
the US used a QIP process to increase the proportion of
14–18 year olds tested for chlamydia [20]. The study in-
creased the proportion of males tested for chlamydia from
0 to 60 % in QIP sites compared with 0 to 5 % in control
sites. This was achieved through providing training, devel-
oping testing protocols and reviewing these protocols
every month with the clinic team and discussing ways to
reduce barriers to testing and ways to actively increase
testing. In Australia, a sexual health intervention was in-
troduced in primary health care centres which used a
similar QIP process described in the US study [21]. The
intervention was able to increase chlamydia testing rates
from 6 to 10 % in females and from 4 to 6 % in males. The
project in Australia also conducted interviews with clinic
staff to examine what strategies could further increase
testing rates. Responses included, financial incentives for
physicians, health promotion targeting young people to
increase patient demand for testing and ensuring quality
data is provided to monitor the clinic’s performance and
provide regular feedback to clinic staff [21].
This study evaluates the impact of a sexual health QIP
on chlamydia and gonorrhoea testing rates and positivity
among 15–29 year olds attending four ACCHS in re-
gional areas of NSW.
Methods
Setting
This study was conducted in the context of a sexual health
QIP called SHIMMER. SHIMMER was conducted in col-
laboration with four ACCHS located in regional areas of
NSW, Australia [22–24]. The ACCHS varied in size and
scope of medical, allied health and health education services
to local Aboriginal communities.
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Quality improvement program
The QIP used in SHIMMER was adapted from another
QIP project known as STRIVE (STIs in Remote com-
munities: ImproVed & Enhanced primary health care
trial) [25]. STRIVE is a cluster randomised control
trial in 65 remote Aboriginal primary health care
centres in Northern Australia. The aim of STRIVE was
to decrease the prevalence of chlamydia, gonorrhoea
and trichomonas among 16–34 year olds through a
QIP process that aims to increase testing and improve
the management of these infections. The QIP process
in STRIVE involved;
1. The extraction of attendance and STI testing data
from the electronic patient system;
2. Developing indicators based on local STI guidelines
and producing reports based on these indicators;
3. Providing monetary incentives if an increase in
testing rates were achieved;
4. Using a systems assessment tool to review their STI
program more broadly;
5. A coordinator (nurse or sexual health physician)
visiting the Aboriginal primary health care centres
every 6-months to present the STI reports and
facilitating a conversation with clinic staff to develop
STI testing and management strategies and
document these into an action plan.
SHIMMER involved a similar QIP process to STRIVE,
except;
1. A sexual health physician and project manager
visited the ACCHS more frequently (every four to
six months (a total of five visits per ACCHS over a
two year period);
2. The indicators were based on national STI
guidelines;
3. SHIMMER provided an annual payment to each
ACCHS that was not performance based; and
4. A clinical audit was conducted to examine the
reasons why 15–24 year olds attended the ACCHS
and what types of consultations (described in the
statistical analysis section) included chlamydia and
gonorrhoea testing.
The STI testing and management strategies developed by
the ACCHS staff during the visits were specific to each
ACCHS to maximise the success of the strategies to
increase STI testing rates (Table 1). The project manager
was an Aboriginal man who co-delivered the intervention
with a sexual health physician. The ethical conduct of
SHIMMER was guided by the Australian National Health
and Medical Research Council Guidelines for Ethical
Conduct in Aboriginal and Torres Strait Islander Health
Research [26]. This document strongly encourages research
projects to have a project reference group where Aboriginal
people are active members in all aspects of the research
including the design, implementation, and interpretation of
the results [26]. Peer-based interventions and health pro-
motion is a well-accepted means of reaching marginalised
communities. In the US, breast cancer programs delivered
by Native American health workers to Native American
communities increased the recruitment of Native Ameri-
cans in the program, increased breast cancer screening, re-
screening, and decreased perceived barriers to screening.
This study also observed increases in knowledge regarding
Pap tests, cervical cancer and awareness of cervical cancer
issues [27, 28].
Evaluation design
A before and after study design was used. Attendance and
STI testing data from the ACCHS was used to calculate the
proportion of 15–29 year olds tested and tested positive for
chlamydia and gonorrhoea, during a 12-month before
period (March 2010 to February 2011) compared with a
12-month QIP period (March 2012 to February 2013). We
chose the 12-month before period because during the 12-
months prior to the QIP period (March 2011 to February
2012) the SHIMMER researchers were in discussions with
each ACCHS to establish the project and clinic staff knew
that a sexual health QIP was going to occur, which poten-
tially could have influenced staff offering more STI testing
as result of these initial project discussions. As a result the
chosen 12-month before period provides a more accurate
baseline period that is not influenced by the establishment
of the SHIMMER project. We also conducted a clinical
audit to determine why 15–24 year olds were attending the
ACCHS and the type of consultations where chlamydia and
gonorrhoea testing occurred during a six-month before
period (1st July to 31st December 2011) compared with a
six-month QIP period (1st July to 30th November 2012).
Data sources
1. Attendance, testing and positivity data
We used a data extraction tool called ‘GeneRic
Health Network Information Technology for the
Enterprise’ (GRHANITETM) [29] to extract
attendance and STI testing data on a weekly basis
through the internet from the electronic patient
system of each ACCHS. The software was
installed just prior to the QIP commencing
and the first extraction included two years of
retrospective data. Data included a unique
de-identified patient number, gender, age,
Aboriginal status, practitioner type (physician,
nurse or dentist), consultation date, chlamydia and
gonorrhoea testing and result.
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2. Clinical audit
A sexual health physician conducted a clinical audit
of 100 individuals aged 15–24 years who attended in
a six-month before period and a six-month QIP
period. Attendees were sorted by name, and all
consultations of the first 50 females and 50 males in
the two time periods were reviewed. The audit
focused on a younger age group compared with
GRHANITETM for two reasons. Firstly, the audit
was resource intensive (a week at each ACCHS) and
secondly, over the past decade chlamydia positivity
has been highest among 15–24 year olds. Data
extracted included a de-identified patient number,
gender, age, consultation date, consultation type (the
reason they attended the ACCHS), if a chlamydia
and gonorrhoea test occurred, test results and
potential STI symptoms. Two of the ACCHS did not
have a total of 50 males who attended in both the
six-month before period or the six-month QIP
period and as a result the total number of individuals
in the before and QIP periods are not the same.
Statistical analysis
Using the GRHANITE™ data, the proportion of 15–29 year
olds tested for chlamydia and gonorrhoea was calculated as
follows; in each 12-month period, the number of individ-
uals tested divided by the number of individuals who
attended (repeat tests and visits of the same person were re-
moved). The proportion of 15–29 year olds testing positive
for chlamydia and gonorrhoea was calculated as follows; in
each 12-month period, the number of individuals who
tested positive divided by the number of individuals who
were tested (repeat positives and tests of the same person
were removed).
Using the clinical audit data, the proportion of 15–24
year olds tested for chlamydia and gonorrhoea by consult-
ation type was calculated as follows; in each six-month
period, the number of individuals tested by the number of
individuals who attended (repeat tests and visits of the
same person were removed). The consultation types were
divided into six categories; STI symptom/check (STI check,
discharge, dysuria), reproductive health (contraception,
pap smear, pregnancy test); adult health check (a general
health assessment which includes around ten clinical
assessments/tests and is recommended annually to 15–54
year old Aboriginal people, each ACCHS decides which
tests are included in their template); general medical (ear,
nose and throat, skin, respiratory tract infection, urinary
tract infection, back pain, migraines, thyroid problems,
referrals, vaccinations, smoking cessation); mental health
(depression, anxiety, suicidal thoughts); and injury (broken
bones, bruises). As people can attend for multiple reasons,
we created a hierarchy in the order above. For example, if a
consultation included a discussion about STI symptoms/
check and mental health, it was identified as a STI symp-
tom consultation. In both data sources, allied health con-
sultations such as dental and physiotherapy were excluded
as these practitioners cannot offer STI testing, treatment
and education.
A chi-squared test was used to assess if patient demo-
graphics (gender, age group, Aboriginal status and ACCHS)
and the proportion of 15–29 year olds ever tested for
chlamydia and gonorrhoea were significantly different
in the 12-month before period compared with the 12-
month QIP period. Logistic regression was used to
Table 1 Examples of STI testing and management strategies used by the ACCHS
Goal Strategy Who
To increase chlamydia & gonorrhoea testing Add chlamydia & gonorrhoea testing to the adult health checka template Practice manager
Offer more Adult Health Checks to 15–29 year olds All clinic staff
Offer testing to any females or male aged 15–29 years All clinic staff
Offer testing to any female aged 15–29 years who attends for a Pap smear,
a pregnancy test, contraception or antenatal care
All clinic staff
Place laminated reminders to test 15–29 year olds near urine pots kept in
consult rooms and stock room. Attached laminated reminder to test where
pregnancy kits are kept
Practice manager
Place laminated reminder to test next to contraceptive devices (e.g. Implanon,
contraceptive pills)
Improve STI re-testing Anyone who tests positive for chlamydia and/or gonorrhoea - enter recall
into patient system for a re-test 3-months after treatment
All clinic staff
Anyone aged 15–29 years who tests negative - Enter recall into patient system
for re-test in 12 months.
Place laminated signs in treatment cupboard to enter recall into patient system
for a re-test 3 months after treatment of chlamydia or gonorrhoea
aAdult health check is a general health assessment used by ACCHS
Graham et al. BMC Infectious Diseases  (2015) 15:370 Page 4 of 9
assess if the proportion tested for chlamydia and gonor-
rhoea was significantly different in the before period
compared with the QIP period by gender, age group
and Aboriginal status. Odds ratios (OR) and their 95 %
confidence intervals (95 % CI) were calculated with
statistical significance at p < 0.05. Data were analysed
using STATA 12 statistical software (STATA Corpor-
ation, College Station TX) and Microsoft Excel 2007.
Ethical approval was received from the Aboriginal Health
& Medical Research Council of NSW Ethics Committee,
the UNSW Australia Human Research Ethics Committee
and the Boards of each participating ACCHS. The SHIM-
MER project was funded by the NSWMinistry of Health.
Results
Attendance
Using the GRHANITE™ data, there were 1881 individ-
uals aged 15–29 years who attended in the before period
and 2259 in the QIP period. In the audit, there were 408
individuals aged 15–24 years in the before period and
437 in the QIP period.
Testing rates
Using the GRHANITE™ data, the proportion tested for
chlamydia in the before period was 9 %, increasing to 22 %
(Table 2) in the QIP period (OR: 1.43, 95 % CI: 1.22-1.67).
In the QIP period, a higher testing rate was achieved in
females; increasing from 13 % to 25 % (OR: 1.32, 95 % CI:
1.10-1.59). However the increase was greater in 20–24 year
old males due to the lower testing rates in the before
period; increasing from 3 % to 17 % (OR: 1.65, 95 % CI:
1.01-2.69, Table 2). Among females, the highest testing rate
achieved in the QIP period was in 15–19 year olds, increas-
ing from 16 % to 29 % (OR: 1.02, 95 % CI: 0.75-1.37). Test-
ing rates varied in the four ACCHS sites, with three
showing significant increases between the before and QIP
periods and one having moderate increases. ACCHS site 1
achieved the highest testing rates in 15–29 year olds, in-
creasing from 10 % to 40 % in females and from 2 % to
27 % in males (Table 2). Similar increases were observed
for gonorrhoea testing (Table 2).
Consultation types
In the clinical audit, chlamydia testing in the before period
was most commonly conducted when patients presented
with STI symptoms/check, reproductive health, or adults
health checks, but these types of consultations only
accounted for a combined total of 31 % of total consulta-
tions; with general medical consultations accounting for
the largest proportion of consultations (56 %). Among
females, the proportion tested for chlamydia increased
during the following consultation types; STI symptom/
checks (from 65 % in the before to 80 % in the QIP period,
adult health check (50 % to 62 %) and reproductive health
(29 % to 39 %) consultations (Table 3). Among males, the
proportion tested for chlamydia increased during STI
symptom/checks (67 % to 70 %), adult health check (50 %
to 75 %) and mental health (14s % to 37 %) consultations
(Table 3). Similar increases were observed for gonorrhoea
testing however the relative increase was greater as fewer
gonorrhoea tests were conducted during the before period
compared with chlamydia (Table 3).
Positivity
Using the GRHANITE™ data, there were 70 (11 %) chla-
mydia diagnoses, increasing from 24 in the before period
to 46 in the QIP period. In females, the number of chla-
mydia diagnoses increased from 18 to 33 and in males
from 6 to 13. The highest number of chlamydia diagno-
ses for both females and males occurred in 15–19 year
olds (71 %), 35 for females and 15 for males. There were
577 gonorrhoea tests conducted over both periods with
4 (0.7 %) testing positive.
Discussion
This study highlights that SHIMMER was able to signifi-
cantly increase the proportion of 15–29 year olds tested for
chlamydia and gonorrhoea. The increase in testing predom-
inantly occurred during STI symptoms/check, reproductive
health and adult health check consultations. However an
increase in testing did not occur during general medical
consultations, which provided the most opportunities to
increase testing. Double the number of chlamydia diagno-
ses were detected during the QIP period compared with
the before period and over the whole study period there
were only four gonorrhoea diagnoses.
The main strength of SHIMMER was that we were able
to collect a large sample size of 15–29 year olds and collect
data from two sources. The clinical audit provided context-
ual information on why 15–24 year olds attended the
ACCHS and the consultation types where testing had
occurred. There are a few limitations to consider when
interpreting our findings. Firstly, only four ACCHS partici-
pated in SHIMMER, as a result our results may not be
generalisable to all ACCHS in NSW or Australia. Secondly,
our study was based on attendance and testing data that
was entered into the electronic patient records system,
therefore if consultations or testing were not entered into
the system it may have resulted in our study under-
estimating the testing rates and positivity in the ACCHS.
Thirdly, it is possible that young people could have also
been tested for STIs at other health care centres in
these regional towns, which would result in our study
under-estimating the testing rates. However we do not
think this would have been common as other studies
have demonstrated that young Aboriginal people prefer
to attend ACCHSs for STI testing [30]. A recent study
included data from six ACCHS and 25 general practice
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centres in Australia and highlighted that only 1 % of
16–29 year olds who attended general practice centres
were Aboriginal compared with 85 % who attended the
ACCHS [31]. The above mentioned study also highlighted
that the chlamydia testing rates among the young Aborigi-
nal attendees were 20 % at ACCHS and 4 % at general
practice centres [31]. Fourthly, we could not determine if
the 15–29 year olds were local residents or visitors from
other Aboriginal communities. If we were able to focus on
just local residents the proportion of 15–29 year olds tested
in this study may have been higher. It is acknowledged that
the repeat visits by the sexual health physician and the pro-
ject manager could have impacted upon the testing rates as
the ACCHS clinic staff knew they would return on a regu-
lar basis to monitor their progress. Finally, our evaluation
focused on the impact of the QIP on STI testing rates and
did not involve a process or economic evaluation.
Overall the proportion of 15–29 year olds tested for
chlamydia during the QIP period was 22 %, which is
almost three-times greater than the 9 % in the before
Table 2 Proportion tested for chlamydia and gonorrhoea in the baseline compared with the quality improvement program (QIP)
period by demographic factors and ACCHS site
Chlamydia testing Gonorrhoea testing
Period Period
Demographic factors & ACCHS site Baseline QIPa P-valueb Baseline QIPa P-valueb
n (%) n (%) n (%) n (%)
Overall 175 (9) 492 (22) <0.001 116 (6) 461 (20) <0.001
Females
Overall 150 (13) 335 (25) <0.001 94 (7) 306 (23) <0.001
Age group (years)
15-19 61 (16) 132 (29) <0.001 34 (9) 121 (27) <0.001
20-24 59 (14) 119 (24) 43 (10) 110 (22)
25-29 30 (9) 84 (21) 17 (5) 75 (19)
Aboriginal status
Aboriginal 133 (14) 291 (27) <0.001 83 (9) 266 (25) <0.001
Non-Aboriginal 17 (8) 43 (15) 11 (5) 39 (14)
ACCHS sitec
1 13 (10) 74 (40) <0.001 0 (0) 69 (37) <0.001
2 104 (22) 149 (32) 73 (15) 137 (29)
3 9 (6) 28 (7) 7 (3) 22 (5)
4 24 (8) 84 (29) 14 (5) 78 (27)
Males
Overall 25 (3) 157 (17) <0.001 22 (3) 155 (17) <0.001
Age group (years)
15-19 11 (4) 58 (17) <0.001 10 (3) 58 (17) <0.001
20-24 7 (3) 56 (19) 5 (2) 55 (19)
25-29 7 (3) 43 (15) 7 (2) 42 (14)
Aboriginal status
Aboriginal 24 (4) 140 (18) <0.001 21 (3) 138 (18) <0.001
Non-Aboriginal 1 (1) 17 (11) 1 (1) 17 (11)
ACCHS sitec
1 3 (2) 42 (27) <0.001 0 (0) 42 (27) <0.001
2 20 (7) 68 (17) 20 (7) 65 (17)
3 1 (1) 15 (7) 1 (1) 16 (7)
4 1 (1) 32 (19) 1 (1) 32 (19)
aQIP (quality improvement program)
bPearson χ2 test (significance p < 0.05)
cAboriginal Community Controlled Health Service
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period. However one ACCHS in this study was able to in-
crease their testing rate to 40 % among 15–29 year old
females. The varying impact seen among ACCHS high-
lights two factors, that various factors can influence the
success of the QIP process on testing rates in different
ACCHS and the need to tailor QIP to each ACCHS as
they have different staffing levels, resources, outreach and
training levels. Although the 22 % in our study was lower
than the 45 % achieved in US paediatric clinics [20], the
magnitude of change in our program is similar to the US
program due to the lower levels of testing among ACCHS
in the 12-month before period. Also SHIMMER included
a larger age group, and as a result demonstrated that the
QIP was beneficial in the age group recommended by
Australian STI testing guidelines for Aboriginal people
[32]. During the QIP period in our study, 25 % of females
and 17 % of males were tested for chlamydia, which was
greater than the other QIP program in Australia imple-
mented in regional primary health care centres in NSW,
which resulted in 10 % of females being tested, with the
increase predominantly occurring during consultations
that included a Pap smear [21].
In SHIMMER, higher chlamydia testing rates were found
among young people attending for STI symptoms/checks,
reproductive health consultations and adult health checks
(AHC). For every completed AHC the ACCHS can receive
$212 from the Australian government’s Medicare Benefits
Scheme. A completed AHC can be conducted and charged
every nine-months [33]. If STI testing is added to the AHC
template and more AHC are offered to young people, this
may increase testing rates. This study also highlighted that
not all STI symptoms/check consultations included a chla-
mydia and /or gonorrhoea test. This highlights the asymp-
tomatic nature of chlamydia and gonorrhoea and if mild
symptoms are present, these can be misinterpreted as other
conditions. This also highlights the need for clinic staff to
receive STI training so they are more aware of the mild
symptoms of chlamydia and gonorrhoea. However the most
Table 3 Proportion tested for chlamydia and gonorrhoea in the baseline compared with the quality improvement program (QIP)
audit by consultation type
Patient gender &
consultation types
Consultations Chlamydia testing Gonorrhoea testing
Period Period Period
Baseline QIPa Baseline QIPa p-valueb Baseline QIPa p-valueb
n (%) n (%) n (%) n (%) n (%) n (%)
Overall 408 (48) 437 (52) 95 (23) 109 (25) 0.573 49 (12) 107 (24) <0.001
Females
Overall 248 (61) 226 (52) 58 (23) 68 (30) 0.099 34 (14) 64 (28) <0.001
Consultations types
General medicalc 140 (56) 104 (46) 19 (14) 12 (12) 0.637 11 (8) 11 (11) 0.463
STI symptom/ checkd 20 (8) 25 (11) 13 (65) 20 (80) 0.258 8 (40) 21 (84) 0.002
Reproductive Healthe 55 (22) 61 (27) 16 (29) 24 (39) 0.246 9 (16) 21 (34) 0.027
Adult Health Checkf 12 (5) 16 (7) 6 (50) 10 (62) 0.508 3 (25) 10 (62) 0.049
Mental healthg 17 (7) 13 (6) 3 (18) 2 (15) 0.869 3 (18) 1 (8) 0.238
Injuryh 4 (2) 7 (3) 1 (25) 0 (0) 0.165 0 (0) 0 (0) N/A
Males
Overall 159 (39) 210 (48) 37 (23) 41 (19) 0.387 15 (9) 43 (20) 0.004
Consultations types
General medicalc 95 (59) 132 (62) 14 (15) 8 (6) 0.029 5 (5) 8 (6) 0.788
STI symptom/ checkd 9 (5) 10 (5) 6 (67) 7 (70) 0.876 4 (44) 7 (70) 0.260
Adult Health Checkf 26 (16) 24 (11) 13 (50) 18 (75) 0.069 4 (15) 19 (79) 0.053
Mental healthg 14 (8) 19 (9) 2 (14) 7 (37) 0.150 2 (14) 7 (37) 0.150
Injuryh 15 (9) 25 (12) 2 (13) 1 (4) 0.278 0 (0) 2 (8) 0.261
aQIP (quality improvement program)
bPearson χ2 test (significance p < 0.05)
cGeneral medical (ear, nose and throat, skin, respiratory tract infection, urinary tract infection, back pain, migraines, thyroid problems, referrals, vaccinations,
smoking cessation)
dSTI symptom/check (STI check, discharge, dysuria)
eReproductive health (Pap smear, contraception, antenatal)
fAdult Health Check (a general health assessment which is recommended annually to 15-54 year old Aboriginal people)
gMental Health (depression, anxiety, suicidal thoughts) h Injury (broken bones, bruises)
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effect strategy would be to base testing on the age of at-
tendees to account for those with asymptomatic infection.
Based on the findings from this evaluation, the following
strategies could be considered to increase testing further;
initiatives to integrate testing into general medical consulta-
tions; offering more AHC to young people; and health
promotion programs that encourage young people to
present more frequently to the ACCHS and request STI
testing or a combination of both. This is supported by an
analysis of baseline data from SHIMMER which highlighted
that chlamydia testing was strongly associated with those
15–29 year olds who attended the ACCHS more frequently
compared with those who attended once to twice over a
three-year period (OR:16.97) [22].
This study showed that as testing increased so did the
number of chlamydia diagnoses. The highest chlamydia
positivity was among 15–24 year olds which is consistent
with national surveillance in Australia [1] and an analysis
of chlamydia infections conducted in Aboriginal primary
health care centres in remote areas of Northern Australia
[34]. We found gonorrhoea positivity was very low over
both periods. As gonorrhoea prevalence can fluctuate
quickly [35], it is important to achieve high levels of gon-
orrhoea and chlamydia testing so that any infection is
detected early and treatment provided. The increasing use
of NAAT equipment by laboratories in Australia to test
for chlamydia and gonorrhoea at the same time will assist
in achieving higher testing rates of gonorrhoea [15].
Some aspects of the quality improvement process used
in SHIMMER could be used in other primary health care
settings (visits, reports, feedback), as currently being
utilised in the Australian Chlamydia Control Effectiveness
Pilot (ACCEPt) project – a trial of chlamydia screening in
general practice clinics [36]. However some of the STI
testing strategies developed by the ACCHS in SHIMMER
are specific to Aboriginal people, such as adult health
checks, which saw an increase in the testing rates however
these are not offered in non-Aboriginal general practice
clinics. The other testing and management strategies listed
in Table 1 could be used to increase STI testing and im-
prove the management of STIs among young people at-
tending general practice clinics.
Conclusions
This evaluation of the SHIMMER project demonstrated
that a sexual health QIP was able to significantly increase
chlamydia and gonorrhoea testing in young Aboriginal
people and detect more infections. The strategies devel-
oped and implemented by the ACCHSs staff aimed to be-
come routine clinical practice that could result in
sustainable long term changes. The QIP process used in
SHIMMER could be introduced in other primary health
care centres to improve the testing and management of
other infection/ conditions.
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